Ajinomoto Co. AJNMY
—
32.28
0.76
2.41%
as of 25 Sep
- Market cap
- —
- P/E
- 39.8×
Follow AJNMY
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
44.95 | — | — | 35.06 |
+8 more quarters Free account |
P/S ratio |
3.51 | — | — | 2.72 | |
P/FCF ratio |
46.28 | — | — | 20.05 | |
P/Operating CF |
300.27 | — | — | 127.06 | |
P/B ratio |
6.52 | — | — | 5.03 | |
Price to Tangible BV |
8.75 | — | — | 6.86 | |
EV/Sales |
3.63 | — | — | 2.89 | |
EV/EBITDA |
21.42 | — | — | 18.85 | |
EV/Operating CF |
19.80 | — | — | 11.37 | |
EV/FCF |
47.84 | — | — | 21.27 | |
Quick Ratio |
0.78 | 0.84 | 0.81 | 0.87 | |
Current Ratio |
1.45 | 1.51 | 1.62 | 1.59 | |
Net Debt/EBITDA |
2.35 | 0.00 | 0.00 | 3.34 | |
Debt/Assets |
21.74% | 23.56% | 25.59% | 25.66% | |
Debt/Equity |
0.50 | 0.55 | 0.57 | 0.58 | |
Asset Turnover |
0.83 | 0.00 | 0.00 | 0.79 | |
Operating CF/Net income |
0.51 | 0.00 | 0.00 | 0.94 | |
Capex/Depreciation |
(1.41) | (1.16) | (1.06) | (1.44) | |
Interest Coverage |
0.00 | — | — | 0.00 | |
Research and Development Expense of Revenue |
1.93% | — | — | 2.02% | |
Selling, General and Administrative Expense of Revenue |
24.08% | — | — | 24.05% | |
Intangible Assets out of Total Assets |
0.11 | 0.11 | 0.12 | 0.12 | |
Share Based Compensation of Revenue |
0.00% | — | — | 0.00% | |
Graham Net Nets |
(0.05) | — | — | (0.06) | |
Graham Number |
10.09 | — | — | 9.64 | |
Earnings Yield |
2.22% | — | — | 2.85% | |
Free Cash Flow Yield |
2.16% | — | — | 4.99% | |
Revenue per Share |
2.71 | — | — | 2.54 | |
Operating CF per Share |
0.12 | 0.00 | 0.00 | 0.21 | |
Capex per Share |
(0.22) | 0.00 | 0.00 | (0.21) | |
Free Cash Flow per Share |
(0.10) | 0.00 | 0.00 | 0.00 | |
Cash per Share |
1.55 | 0.00 | 0.00 | 1.49 | |
Shareholders Equity per Share |
5.59 | 0.00 | 0.00 | 5.37 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.59 | 0.00 | 0.00 | 5.37 | |
Free Cash Flow |
(92.06) | 574.05 | 269.52 | 0.99 | |
Working Capital |
1,622.69 | 1,783.17 | 1,842.55 | 1,881.10 | |
Capital Expenditures |
(208.03) | (494.32) | (154.61) | (208.90) | |
Net Current Asset Value |
(1,632.66) | (1,757.93) | (1,708.77) | (1,703.37) | |
EV/EBIT |
28.79 | — | — | 23.22 | |
Capex to Sales |
0.08 | 0.00 | 0.00 | 0.08 | |
Net Profit Margin |
8.85% | — | — | 8.85% | |
Price to Operating Income |
27.85 | — | — | 21.88 | |
| Other line items | |||||
Average Receivables |
1,320.90 | 1,403.66 | 1,305.55 | 1,403.38 | |
Average Payables |
1,633.83 | 1,616.22 | 1,572.85 | 1,526.67 | |
Average Inventory |
2,099.16 | 2,179.60 | 2,084.38 | 1,966.13 | |
Average Assets |
11,986.20 | 12,190.86 | 11,887.64 | 12,492.34 | |
Average Common Equity |
5,523.36 | 5,763.62 | 5,765.53 | 5,731.19 |
Columns are period end dates